Oakland County Drug DUI Lawyer Paul J. Tafelski Issues Guidance On Prescription Drugs and Driving In Michigan

Bloomfield Hills, MI – Paul J. Tafelski of Michigan Defense Law (https://www.michigandefenselaw.com/blog/six-things-to-know-about-prescription-drugs-and-driving-in-michigan/) has released detailed guidance to help drivers understand how Michigan treats impairment involving lawful medications and controlled substances. The initiative addresses growing concerns about prescription drug use behind the wheel and provides practical information on legal standards, enforcement practices, and defense considerations. As […]

Cygnet Energy Ltd. and Kiwetinohk Energy Corp. Announce Completion of Arrangement

CALGARY, Alberta, Dec. 18, 2025 (GLOBE NEWSWIRE) — Cygnet Energy Ltd. (“Cygnet“) and Kiwetinohk Energy Corp. (“Kiwetinohk“) (TSX: KEC) are pleased to announce the completion of the acquisition of Kiwetinohk by Cygnet. As previously announced, all outstanding common shares of Kiwetinohk (the “KEC Shares“) were acquired by Cygnet pursuant to a plan of arrangement under

NeuExcell Therapeutics Reports Encouraging Clinical Results with World’s First In Situ Conversion Therapy for Malignant Glioma

SINGAPORE, Dec. 18, 2025 (GLOBE NEWSWIRE) — NeuExcell Therapeutics announced encouraging clinical results of NXL-004, the world's first in situ conversion gene therapy for malignant glioma. The data were presented at the ESMO Asia Congress 2025, December 5-7 in Singapore. Recurrent malignant glioma carries an extremely poor prognosis, with median survival under nine months. NXL-004

CSE Bulletin: Reinstatement – ASEP Medical Holdings Inc. (ASEP)

Toronto, Ontario–(Newsfile Corp. – Le 18 décembre/December 2025) – Effective immediately, ASEP Medical Holdings Inc. will be reinstated for trading. The Company has rectified the default situation that gave rise to the suspension. _________________________________ En vigueur immédiatement, ASEP Medical Holdings Inc. sera rétabli pour le commerce. La Société a rectifié la situation par défaut qui

Canadian Investment Regulatory Organization Trading Halt – CHS

The following issues have been halted by CIRO Company: Comprehensive Healthcare Systems Inc. TSX-Venture Symbol: CHS All Issues: Yes Reason: Pending News Halt Time (ET): 11:34 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair

KRAUSE GROUP RELEASES 2024 CORPORATE SOCIAL RESPONSIBILITY REPORT

Krause Group today announced the release of its 2024 Corporate Social Responsibility Report, highlighting progress across its global footprint in Iowa and Italy and reaffirming the company's commitment to operating with integrity, respect, and a deep sense of responsibility to the communities it serves. The report outlines advancements across key focus areas, including climate action,

Cygnet Energy Ltd. and Kiwetinohk Energy Corp. Announce Completion of Arrangement

Cygnet Energy Ltd. and Kiwetinohk Energy Corp. Announce Completion of Arrangement GlobeNewswire December 18, 2025 CALGARY, Alberta, Dec. 18, 2025 (GLOBE NEWSWIRE) — Cygnet Energy Ltd. (“Cygnet“) and Kiwetinohk Energy Corp. (“Kiwetinohk“) (TSX: KEC) are pleased to announce the completion of the acquisition of Kiwetinohk by Cygnet. As previously announced, all outstanding common shares of

INVESTOR REMINDER: Berger Montague Notifies Telix Pharmaceuticals Ltd. (TLX) Investors of a Class Action Lawsuit and Deadline

Philadelphia, Pennsylvania–(Newsfile Corp. – December 18, 2025) – National plaintiffs’ law firm Berger Montague PC announces that a class action lawsuit has been filed against Telix Pharmaceuticals Ltd. (NASDAQ: TLX) (“Telix” or the “Company”) on behalf of investors who purchased Telix securities during the period of February 21, 2025 through August 28, 2025 (the “Class

NeuExcell Therapeutics Reports Encouraging Clinical Results with World’s First In Situ Conversion Therapy for Malignant Glioma

NeuExcell Therapeutics Reports Encouraging Clinical Results with World's First In Situ Conversion Therapy for Malignant Glioma GlobeNewswire December 18, 2025 SINGAPORE, Dec. 18, 2025 (GLOBE NEWSWIRE) — NeuExcell Therapeutics announced encouraging clinical results of NXL-004, the world's first in situ conversion gene therapy for malignant glioma. The data were presented at the ESMO Asia Congress

James Hardie Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against James Hardie Industries plc – JHX

(NYSE:JHX), NEW ORLEANS, Dec. 18, 2025 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until December 23, 2025 to file lead plaintiff applications in a securities class action lawsuit against James Hardie Industries plc (“James Hardie” or the “Company”) (NYSE: JHX), if they purchased or otherwise acquired the Company's

Scroll to Top